# NIPRIDE RTU

NDC: 51754-1029
Generic name: Sodium Nitroprusside
Labeler / Manufacturer: EXELA PHARMA SCIENCES, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180720

FDA application: NDA209387

## Active ingredients

- SODIUM NITROPRUSSIDE: .2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51754-1029"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51754-1029
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5acf0836-93ff-4064-b888-3f560e8a558d